Atomic Resolution Structure of Monomorphic Aβ42 Amyloid Fibrils

Michael T Colvin1, Robert Silvers1, Qing Zhe Ni1

  • 1Department of Chemistry and Francis Bitter Magnet Laboratory, Massachusetts Institute of Technology , Cambridge, Massachusetts 02139, United States.

Insights

Researchers determined the atomic structure of amyloid-beta 42 (Aβ42) fibrils, revealing a dimeric core crucial for Alzheimer's disease pathogenesis. This structure aids in developing new Aβ42 aggregation inhibitors.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Structural Biology

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) fibrils.
  • Aβ42 is the more neurotoxic and critical form for AD etiology.
  • Understanding Aβ fibril structure is key to developing AD therapies.

Purpose of the Study:

  • To determine the atomic resolution structure of Aβ42 amyloid fibrils.
  • To elucidate the molecular arrangement and interactions within Aβ42 fibrils.
  • To provide a structural basis for designing Aβ42 aggregation inhibitors.

Main Methods:

  • High-field magic angle spinning NMR spectroscopy.
  • Collection of over 500 (13)C-(13)C, (13)C-(15)N distance and backbone angle constraints.
  • Atomic resolution structure determination (PDB ID: 5KK3).

Main Results:

  • Revealed a fibril core composed of a dimer of Aβ42 molecules.
  • Each monomer adopts an S-shaped fold with four β-strands.
  • Identified specific inter-monomer contacts (M35, L17, Q15) and parallel in-register arrangement.
  • Outer surfaces are hydrophilic, while two hydrophobic cores are formed within the dimer.

Conclusions:

  • The determined Aβ42 fibril structure offers insights into its aggregation mechanism.
  • The structure facilitates the design of drugs targeting fibril surfaces to inhibit secondary nucleation.
  • This work provides a foundation for novel therapeutic strategies against Aβ42 aggregation in Alzheimer's disease.